United States securities and exchange commission logo

                          October 17, 2022

       Ryan Debski, Esq.
       Executive Vice President and General Counsel
       Eagle Pharmaceuticals, Inc.
       50 Tice Boulevard, Suite 315
       Woodcliff Lake, NJ 07677

                                                        Re: Eagle
Pharmaceuticals, Inc.
Statement on Form S-3
                                                            Filed October 11,
                                                            File No. 333-267827

       Dear Ryan Debski:

              This is to advise you that we have not reviewed and will not
review your registration

               Please refer to Rules 460 and 461 regarding requests for
acceleration. We remind you
       that the company and its management are responsible for the accuracy and
adequacy of their
       disclosures, notwithstanding any review, comments, action or absence of
action by the staff.

                                                        Please contact Alan
Campbell at 202-551-4224 with any questions.


                          Division of Corporation Finance

                          Office of Life Sciences
       cc:                                              Sarah Sellers, Esq.